PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,352,000 | -16.5% | 1,710,265 | 0.0% | 0.43% | -33.2% |
| Q2 2022 | $24,371,000 | -31.6% | 1,710,265 | 0.0% | 0.65% | -16.3% |
| Q1 2022 | $35,608,000 | -9.9% | 1,710,265 | 0.0% | 0.78% | +11.5% |
| Q4 2021 | $39,507,000 | -22.5% | 1,710,265 | 0.0% | 0.70% | -1.3% |
| Q3 2021 | $50,966,000 | -12.8% | 1,710,265 | 0.0% | 0.71% | -24.7% |
| Q2 2021 | $58,423,000 | +3.9% | 1,710,265 | 0.0% | 0.94% | +10.6% |
| Q1 2021 | $56,251,000 | -46.5% | 1,710,265 | 0.0% | 0.85% | -42.4% |
| Q4 2020 | $105,198,000 | +73.3% | 1,710,265 | 0.0% | 1.47% | +32.4% |
| Q3 2020 | $60,714,000 | – | 1,710,265 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |